IS2783B - Lyfjasamsetning sem nær yfir kító-fáliður - Google Patents

Lyfjasamsetning sem nær yfir kító-fáliður

Info

Publication number
IS2783B
IS2783B IS7193A IS7193A IS2783B IS 2783 B IS2783 B IS 2783B IS 7193 A IS7193 A IS 7193A IS 7193 A IS7193 A IS 7193A IS 2783 B IS2783 B IS 2783B
Authority
IS
Iceland
Prior art keywords
oligomers
chitosomes
covers
pharmaceutical composition
treatment
Prior art date
Application number
IS7193A
Other languages
English (en)
Other versions
IS7193A (is
Inventor
Jon M Einarsson
Johannes Gislason
Martin Peter
Sven Bahrke
Original Assignee
Genis Ehf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genis Ehf filed Critical Genis Ehf
Publication of IS7193A publication Critical patent/IS7193A/is
Publication of IS2783B publication Critical patent/IS2783B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IS7193A 2001-09-26 2004-03-22 Lyfjasamsetning sem nær yfir kító-fáliður IS2783B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum
PCT/IS2002/000016 WO2003026677A1 (en) 2001-09-26 2002-09-26 Pharmaceutical composition comprising chito-oligomers

Publications (2)

Publication Number Publication Date
IS7193A IS7193A (is) 2004-03-22
IS2783B true IS2783B (is) 2012-05-15

Family

ID=36700489

Family Applications (2)

Application Number Title Priority Date Filing Date
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum
IS7193A IS2783B (is) 2001-09-26 2004-03-22 Lyfjasamsetning sem nær yfir kító-fáliður

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum

Country Status (13)

Country Link
US (2) US7985741B2 (is)
EP (1) EP1435976B1 (is)
JP (1) JP4613008B2 (is)
KR (1) KR20040062548A (is)
AT (1) ATE359797T1 (is)
CA (1) CA2507926C (is)
DE (1) DE60219653T2 (is)
DK (1) DK1435976T3 (is)
ES (1) ES2284935T3 (is)
IS (2) IS6085A (is)
PT (1) PT1435976E (is)
SI (1) SI1435976T1 (is)
WO (1) WO2003026677A1 (is)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002351576A1 (en) * 2001-12-13 2003-07-09 Ism Biopolymer Inc. Method of modulating release of saccharides and uses thereof
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
CA2540586A1 (en) * 2003-10-01 2005-04-21 Optimer Pharmaceuticals, Inc. Treatment of a condition in a mammal with administration of aminosugar and uses thereof
JP2007525486A (ja) * 2003-11-24 2007-09-06 オプティマー・ファーマスーティカルズ・インコーポレイテッド 化合物の投与による哺乳動物の症状の処置及び化合物の使用方法
JP4496375B2 (ja) * 2004-05-21 2010-07-07 国立大学法人鳥取大学 創傷の治療又は処置のための薬剤
RU2421467C2 (ru) * 2005-06-14 2011-06-20 Дженис Эхф. Композиции частично деацетилированных производных хитина
US7485718B2 (en) 2005-06-16 2009-02-03 E. I. Du Pont De Nemours And Company Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
WO2007001283A2 (en) * 2005-06-16 2007-01-04 E.I. Dupont De Nemours And Company Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
KR100831335B1 (ko) * 2006-06-22 2008-05-22 부경대학교 산학협력단 인간 피부 섬유아세포에서 메트릭스메탈로프로테이나제-2의 발현 및 활성을 억제시키는키토올리고사카라이드 화합물 및 이를 함유한 메트릭스메탈로프로테이나제-2 억제제
DK2318014T3 (en) * 2008-07-18 2016-12-19 Genís Hf New composition for the treatment of autoimmune diseases
KR20100060634A (ko) * 2008-11-28 2010-06-07 (주)아모레퍼시픽 미토콘드리아 활성화를 위한 조성물
KR101729137B1 (ko) * 2009-07-28 2017-04-26 (주)아모레퍼시픽 키토올리고당을 함유하는 피로회복용 조성물
JP6141265B2 (ja) 2011-06-03 2017-06-07 マグワイア アビー， エルエルシー 関節の潤滑性を改善するための方法、組成物及び物品
PL2747565T3 (pl) 2011-09-08 2017-09-29 Novozymes Bioag A/S Sposoby zaprawiania nasion
AU2012308443B2 (en) 2011-09-14 2017-05-04 Novozymes Bioag A/S Use of lipochito-oligosaccharides and/or chito oligosaccharides in combination with phosphate-solubilizing microorganisms to enhance plant growth
MX351416B (es) * 2011-09-23 2017-10-13 Novozymes Bioag As Quitooligosacaridos y metodos para el uso en el mejoramiento de crecimiento de plantas.
RU2016124247A (ru) * 2011-09-23 2018-11-30 Новозимс Биоаг А/С Хитоолигосахариды и способы их применения для усиления роста кукурузы
MX352422B (es) 2012-04-23 2017-11-24 Genis Hf Composiciones de cemento bioactivas de autoendurecimiento con quitina parcialmente desacetilada como sustitutos de injertos de hueso.
JP6285497B2 (ja) * 2016-06-07 2018-02-28 株式会社エバーライフ 鶏冠抽出物含有経口組成物及び鶏冠抽出物の香味に由来する摂取困難性の改善方法
KR101673368B1 (ko) 2016-07-14 2016-11-08 김기혁 공정가스 반응물의 콜드트랩 장치
WO2023205718A2 (en) * 2022-04-21 2023-10-26 Hassan Ameer E Methods of treating inflammation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5919122B2 (ja) * 1976-10-12 1984-05-02 味の素株式会社 水溶性部分脱アセチル化キチン及びその製造法
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
JP2527317B2 (ja) * 1986-12-19 1996-08-21 ライオン株式会社 骨疾患治療剤
US6184037B1 (en) * 1996-05-17 2001-02-06 Genemedicine, Inc. Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
ATE293451T1 (de) * 1996-12-13 2005-05-15 Lescarden Inc Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin
JP3062592B2 (ja) * 1997-05-30 2000-07-10 農林水産省食品総合研究所長 ２−アセチルアミノ−４−Ｏ−（２−アミノ−２−デオキシ−β−Ｄ −グルコピラノシル）−２−デオキシ−Ｄ −グルコースおよびその塩の製造法
US6492350B2 (en) * 2000-01-27 2002-12-10 Jdc (Hawaii) Inc. Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
EP1127574A1 (en) * 2000-02-22 2001-08-29 Food Industry Research and Development Institute Use of chitinous materials for inhibiting cellular nitric oxide production
CA2313836C (en) * 2000-03-15 2009-06-09 Cargill, Incorporated Chitosan and method of preparing chitosan
US20020119949A1 (en) * 2001-02-26 2002-08-29 Asa Hellman Prophylactic teat treatment
RU2421467C2 (ru) 2005-06-14 2011-06-20 Дженис Эхф. Композиции частично деацетилированных производных хитина

Also Published As

Publication number Publication date
US20050004073A1 (en) 2005-01-06
WO2003026677A1 (en) 2003-04-03
IS6085A (is) 2003-03-27
US8415326B2 (en) 2013-04-09
JP2005507891A (ja) 2005-03-24
ATE359797T1 (de) 2007-05-15
SI1435976T1 (sl) 2007-08-31
PT1435976E (pt) 2007-06-28
KR20040062548A (ko) 2004-07-07
DK1435976T3 (da) 2007-08-27
EP1435976B1 (en) 2007-04-18
ES2284935T3 (es) 2007-11-16
US7985741B2 (en) 2011-07-26
CA2507926C (en) 2011-12-20
IS7193A (is) 2004-03-22
DE60219653D1 (de) 2007-05-31
DE60219653T2 (de) 2008-01-03
US20110257381A1 (en) 2011-10-20
CA2507926A1 (en) 2003-04-03
EP1435976A1 (en) 2004-07-14
JP4613008B2 (ja) 2011-01-12

Similar Documents

Publication Publication Date Title
IS2783B (is) Lyfjasamsetning sem nær yfir kító-fáliður
EP2497478A3 (en) Oligosaccaride compositions and use thereof in the treatment of infection
EP2085780A3 (en) Methods and products related to low molecular weight heparin
MY142329A (en) Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents.
MXPA04001876A (es) Uso de fucanos en el tratamiento de adhesiones, artritis y psoriasis.
NO20012000D0 (no) N-(2-aryl-propionyl)-sulfonamider og farmasöytiske sammensetninger som inneholder dem
IL172773A0 (en) Formulations for the treatment of arhritis conditions
HK1064043A1 (en) Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis or chondromalacia
DZ3165A1 (fr) Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie.
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
MY142376A (en) Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
PL375693A1 (en) Aldonic acid esters, methods for producing the same, and methods for producing pharmaceutical active ingredients coupled to polysaccharides or polysaccharide derivatives on free amino groups
PL346143A1 (en) Tan-1057 derivatives
ITMI20021801A1 (it) Prodotti di pomodoro.
DK1362045T3 (da) 2-Thio-substituerede imidazolderivater og deres anvendelse inden for farmacien
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
MXPA06000336A (es) Mezclas de oligosacaridos derivados de la heparina, su preparacion y las composiciones farmaceuticas que las contienen.
NO985414L (no) Farmas÷ytiske formuleringer inneholdende kalium-, natrium- og trioksaprozin salt
IT1314768B1 (it) Processo per la produzione di additivi antifiamma per composizionipolimeriche,e prodotti ottenuti da detto processo
EP1411956B8 (en) Use of oversulfated polysaccharides as inhibitors of hiv
WO2005011611A3 (en) Bicyclic compounds and compositions as pdf inhibitors
AU2000265107A1 (en) Methods and compositions for the prevention and treatment of inflamation, osteoarthritis, and other degenerative joint diseases
DK1301192T3 (da) Anvendelse af polysulfaterede cyclodextriner til behandling af artrose
ATE552004T1 (de) Oral verabreichbare heparinderivate
WO2000056298A3 (en) Treatment of lyme disease with polysulfated glycosaminoglycan formulations